SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-005545
Filing Date
2022-04-11
Accepted
2022-04-11 08:41:21
Documents
8
Period of Report
2022-04-11

Document Format Files

Seq Description Document Type Size
1 6-K 6k_april_rdo__mvil.htm 6-K 53486
2 EX-4.1 mito-ex4_1.htm EX-4.1 226784
3 EX-4.2 mito-ex4_2.htm EX-4.2 111058
4 EX-5.1 mito-ex5_1.htm EX-5.1 39662
5 EX-10.1 mito-ex10_1.htm EX-10.1 379006
6 EX-10.2 mito-ex10_2.htm EX-10.2 168522
7 GRAPHIC img81416145_0.jpg GRAPHIC 38520
8 GRAPHIC img81416145_1.jpg GRAPHIC 6725
  Complete submission text file 0000950170-22-005545.txt   1039449
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 22818552
SIC: 2834 Pharmaceutical Preparations